Skip to content

Clinical trials

Completed Observational Heart Defects, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Observational Status: Completed Clear all

228 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20043
20056
20068
20078
20084
20099
20107
20115
201213
201312
20149
201516
20169
201721
201818
201919
202015
202111
20223
20236
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed228

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University15
University Hospital, Montpellier12
National Heart, Lung, and Blood Institute (NHLBI)11
Boston Children's Hospital8
Medical College of Wisconsin7
Oslo University Hospital6
Children's Hospital Medical Center, Cincinnati4
Children's Hospital of Fudan University4
University Children's Hospital, Zurich4
Children's Mercy Hospital Kansas City3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital228
Cardiovascular Diseases11
Heart Diseases11
Univentricular Heart11
Heart Failure10
Hypoplastic Left Heart Syndrome9
Acute Kidney Injury8
Tetralogy of Fallot8
Cardiomyopathies5
Congenital, Hereditary, and Neonatal Diseases and Abnormalities5

Trials

Showing 1 to 25 of 228. Each trial links to its page on Pharma Observatory.

128 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.